Abstract:Anti-ganglioside antibodies (anti-Gg Abs) have been linked to delayed/poor clinical recovery in both axonal and demyelinating forms of Guillain-Barrè Syndrome (GBS). In many instances, the incomplete recovery is attributed to the peripheral nervous system's failure to regenerate. The cross-linking of cell surface gangliosides by anti-Gg Abs triggers inhibition of nerve repair in both in vitro and in vivo axon regeneration paradigms. This mechanism involves the activation of the small GTPase RhoA, which negatively modulates the growth cone cytoskeleton. At present, the identity/es of the receptor/s responsible for transducing the signal that ultimately leads to RhoA activation remains poorly understood. The aim of this work was to identify the transducer molecule responsible for the inhibitory effect of anti-Gg Abs on nerve repair. Putative candidate molecules were identified through proteomic mass spectrometry of ganglioside affinity-captured proteins from rat cerebellar granule neurons (Prendergast et al., 2014). These candidates were evaluated using an in vitro model of neurite outgrowth with primary cultured dorsal root ganglion neurons (DRGn) and an in vivo model of axon regeneration. Using an shRNA-strategy to silence putative candidates on DRGn, we identified tumor necrosis factor receptor 1A protein (TNFR1A) as a transducer molecule for the inhibitory effect on neurite outgrowth from rat/mouse DRGn cultures of a well characterized mAb targeting the related gangliosides GD1a and GT1b. Interestingly, lack of TNFr1A expression on DRGn abolished the inhibitory effect on neurite outgrowth caused by anti-GD1a but not anti-GT1b specific mAbs, suggesting specificity of GD1a/transducer signaling. Similar results were obtained using primary DRGn cultures from TNFR1a-null mice, which did not activate RhoA after exposure to anti-GD1a mAbs. Generation of single point mutants at the stalk region of TNFR1A identified a critical amino acid for transducing GD1a signaling, suggesting a direct interaction. Finally, passive immunization with an anti-GD1a/GT1b mAb in an in vivo model of axon regeneration exhibited reduced inhibitory activity in TNFR1a-null mice compared to wild type mice. In conclusion, these findings identify TNFR1A as a novel transducer receptor for the inhibitory effect exerted by anti-GD1a Abs on nerve repair, representing a significant step forward toward understanding the factors contributing to poor clinical recovery in GBS associated with anti-Gg Abs.

Tumor Necrosis Factor-Α in Guillain-Barré Syndrome, Friend or Foe?

Tumor Necrosis Factor-Alpha In Guillain-Barre Syndrome, Friend Or Foe?

Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.

Lactobacillus Rhamnosus Ameliorates Experimental Autoimmune Neuritis Via Modulation of Gut Microbiota and Metabolites.

Tumor Necrosis Factor-Alpha In Experimental Autoimmune Neuritis

Are Th17 Cells and Their Cytokines a Therapeutic Target in Guillain–Barré Syndrome?

Can IFN-γ Be a Therapeutic Target in Guillain-Barré Syndrome?

The Role of Cytokines in Guillain–Barré Syndrome

Th17 Cells and Their Cytokines Serve As Potential Therapeutic Target in Experimental Autoimmune Neuritis

Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis

Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?

The Role Of Il-12 And Tnf-Alpha In Aidp And Aman

Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of Mrna Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and Cytolysin

Peripheral Blood and Cerebrospinal Fluid Cytokine Levels in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis

The dynamic expression of canonical Wnt/-catenin signalling pathway in the pathologic process of experimental autoimmune neuritis

Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies

Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.

Autoreactive T cells target peripheral nerves in Guillain–Barré syndrome

IL-10 and IFN-γ in Guillain–Barré syndrome

Enhanced Glycolysis Contributes to the Pathogenesis of Experimental Autoimmune Neuritis.

P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation